| Style | Citing Format |
|---|---|
| MLA | Naser Moghadasi A. "Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed." Multiple Sclerosis and Related Disorders, vol. 56, no. , 2021, pp. -. |
| APA | Naser Moghadasi A (2021). Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed. Multiple Sclerosis and Related Disorders, 56(), -. |
| Chicago | Naser Moghadasi A. "Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed." Multiple Sclerosis and Related Disorders 56, no. (2021): -. |
| Harvard | Naser Moghadasi A (2021) 'Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed', Multiple Sclerosis and Related Disorders, 56(), pp. -. |
| Vancouver | Naser Moghadasi A. Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed. Multiple Sclerosis and Related Disorders. 2021;56():-. |
| BibTex | @article{ author = {Naser Moghadasi A}, title = {Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed}, journal = {Multiple Sclerosis and Related Disorders}, volume = {56}, number = {}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Naser Moghadasi A TI - Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed JO - Multiple Sclerosis and Related Disorders VL - 56 IS - SP - EP - PY - 2021 ER - |